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How action potentials regulate myelination by oligodendrocytes is uncertain. We 
show that neuronal activity raises [Ca2+]i in developing oligodendrocytes in vivo, and 
that myelin sheath elongation is promoted by a high frequency of [Ca2+]i transients 
and prevented by [Ca2+]i-buffering. Sheath elongation occurs ~1 hour after [Ca2+]i 
elevation. Sheath shortening is associated with a low frequency of [Ca2+]i transients 
but with longer duration [Ca2+]i bursts. Thus, [Ca2+]i controls myelin sheath 
development. 
 Neuronal action potentials may regulate myelination, both during development1-3 and 
during white matter plasticity in adulthood4,5. Possible mediators of neuronal activity include 
exocytosis6-8 of glutamate9,10 or GABA11 at synapses between unmyelinated axons and 
oligodendrocyte precursor cells12, or release of growth factors10,13. Within developing 
oligodendrocytes these agents may alter the concentration of calcium14. 
To investigate whether [Ca2+]i regulates myelination in vivo, we studied developing 
oligodendrocytes in the spinal cords of zebrafish (immobilised in agarose at 3 days post-
fertilisation). Their spinal cord was imaged employing membrane-associated fluorescent 
proteins encoded by tg(sox10:mRFP) or tg(mbp:mCherry) transgenes to reveal the structure 
of developing oligodendrocytes, and tg(sox10:GCaMP6s) transgene to monitor [Ca2+]i. In 
some animals CRISPR/Cas9-mediated somatic silencing of the tg(sox10:mRFP) transgene 
in most cells enabled observation of single cells developing. We classified cells into 3 
developmental stages. Pre-myelinating oligodendrocytes (pre-OLs, Fig. 1a) showed many 
processes, none of which had made a sheath. Since tg(sox10:mRFP) can be expressed in 
interneurons, these cells’ identity was confirmed by observing them until they formed myelin 
sheaths. Early oligodendrocytes (early-OLs, Fig. 1b) had started to make sheaths. 
Oligodendrocytes (OLs, Fig. 1c) had initiated formation of all the sheaths that would be 
produced (as confirmed by subsequent observation), placing them past the 5 hour window15 
of sheath initiation, although a small fraction of sheaths could still shorten and disappear in 
these cells15.  
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Cells at all stages exhibited [Ca2+]i transients (quantified as in the Online Methods) in 
their processes and somata (Fig. 1d-f; interactions between [Ca2+]i transients in different 
locations are presented in Supp. Fig. 1). The overall transient rate declined with 
development and was similar (Fig. 1g) in each process (where they may regulate local 
cytoskeletal events and/or protein and lipid synthesis) and in somata (where they may 
regulate gene expression). Because there are many processes per cell (10.3±0.6 analysed 
in pre-OLs, 11.9±0.6 in early-OLs and 6.9±0.6 in OLs), most transients occurred in 
processes rather than somata. However, [Ca2+]i transients were >2-fold longer in the somata 
(Fig. 1h). The amplitude of transients (assessed as F/F, where F is GCaMP6s 
fluorescence) declined in processes with development, and was smaller in somata than in 
processes throughout development (Fig. 1i).  
To determine whether neuronal activity generated oligodendrocyte [Ca2+]i transients, 
we stimulated action potentials electrically or blocked them by injecting TTX (or extracellular 
solution, sham) into the hindbrain, from where it entered the spinal cord (Fig. 2a-c). 
Stimulated action potentials were detected as extracellular field potentials, which were stable 
during sham injections but abolished by TTX (Fig. 2c). Averaging responses to 10 second 50 
Hz stimulation trains revealed that stimulation significantly increased [Ca2+]i, both in 
processes that had not yet made a sheath (“Non-sheath”, part of pre-OLs or early-OLs: Fig. 
2d) and in sheaths of processes that were already myelinating (“Sheath”, part of early-OLs 
or OLs, Fig. 2e). The [Ca2+]i transient amplitude was larger in Non-sheath than in Sheath 
processes (Fig. 2d-e). Stimulation increased the frequency of [Ca2+]i elevations (Fig. 2f-g), 
but by less than the 0.6/min (1/100 sec) increase expected if every stimulation train evoked a 
[Ca2+]i rise. Neuronal stimulation also evoked [Ca2+]i rises in somata of cells with processes 
that had not yet made a sheath, but not in somata of cells that already had a sheath-forming 
process (Fig. 2h-k) implying that at this later developmental stage neuronal activity releases 
factors that raise [Ca2+]i in developing sheaths but not in somata. 
Injecting extracellular solution had no effect on ongoing [Ca2+]i transients in the 
processes and somata of oligodendrocyte-lineage cells, but TTX injection roughly halved the 
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transient rate in processes (Fig. 2l-m). TTX produced a similar reduction of transient rate in 
somata of cells with non-sheath processes (Fig. 2n-o). Thus, approximately half of the [Ca2+]i 
transients in developing oligodendrocytes are driven by axonal action potentials, but the 
remainder occur independently of action potentials.  
To determine whether myelin sheath [Ca2+]i transients regulate sheath growth, we 
imaged growing sheaths in OLs for 10.5 minutes every hour for 5 hours (Fig. 3a-b). This 
allowed measurement of the [Ca2+]i transient frequency without excessive fluorophore 
bleaching or phototoxicity while imaging structural changes over an extended period. Over 5 
hours, the lengths of myelin sheaths increased (44% of 68 sheaths studied), decreased 
(26%), showed no change (24%), or increased then decreased (6%) (Fig. 3c-e). Plotting the 
total change of sheath length against the mean [Ca2+]i transient rate in that sheath over 5 
hours revealed that sheath elongation correlated strongly with [Ca2+]i transient rate (Fig. 3f; 
regression slope is different from zero, p=10-11). However, for a [Ca2+]i transient rate lower 
than ~1/30 mins, sheath retraction occurred. Thus, a threshold rate of [Ca2+] transients may 
be needed to maintain sheath length at this developmental stage.  
Similar plots showed that sheath elongation also correlated weakly but significantly 
(Supp. Fig. 2a-c) with sheath [Ca2+]i transient amplitude, duration and area (ʃ[F/F].dt), but 
not with the somatic [Ca2+]i transient rate (Supp. Fig. 2d). Thus, sheath development is 
correlated with local [Ca2+]i changes but not with somatic changes that might alter global 
gene expression. To assess the temporal relationship between [Ca2+]i elevations and sheath 
length, we selected sheaths which showed no growth for at least one hour (e.g. red lines in 
Fig. 3c), and aligned their time course of sheath elongation and [Ca2+]i transient rate at the 
onset of growth (Supp. Fig. 2e). Plotting sheath growth per hour against mean [Ca2+]i 
transient rate (assessed as the average of the rates in imaging periods bracketing that hour) 
suggested that an increase in transient rate triggers sheath elongation after ~1 hour (Fig. 
3g).  
To demonstrate that the [Ca2+]i transients, including those evoked by neuronal 
activity (Fig. 2), mechanistically drive sheath elongation (rather than merely being correlated 
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with elongation), we first modulated neuronal activity and hence the [Ca2+]i transient rate, 
either increasing neuronal activity with stimulation or decreasing it with TTX (Fig. 3h). 
Stimulation increased sheath elongation by 60% (Fig. 3i), while TTX reduced elongation by 
43% (Fig. 3j). Second, we manipulated the [Ca2+]i changes occurring within growing myelin 
sheaths, by briefly whole-cell patch-clamping developing oligodendrocytes to introduce into 
them solutions of low (1 mM EGTA) or high (30 mM BAPTA) [Ca2+] buffering power (with the 
same free [Ca2+]i: ~63 nM, see Online Methods). Sheaths dialysed with the weak buffer 
continued to elongate over 3 hours, while those dialysed with the strong buffer on average 
shortened (significantly different, p=2x10-4, Fig. 3k). Thus, myelin sheath elongation is driven 
by [Ca2+]i transients, including those evoked by neuronal activity. 
In addition to the temporally-isolated [Ca2+]i transients associated with sheath 
lengthening, we observed a longer type of [Ca2+]i event (‘bursts’, inset to Fig. 3l) exhibiting 
repeated rises and falls of [Ca2+]i (duration 87.5±15.8 sec [mean±SEM, n=7]; mean F/F 
0.52±0.09. These were rare but, strikingly, occurred only in sheaths that were shortening (or 
transitioning from growing to shortening). Consequently, isolated transients and bursts are 
inversely correlated in their association with sheath behaviour (Fig. 3l). On average [Ca2+]i 
bursts contributed only 7.8±2.8% of the Ca2+ entry (calculated as ʃ[F/F].dt) in all sheaths, 
but this was 0% in lengthening sheaths, and 75.6±2.2% in shortening sheaths with bursts. 
Dialysis with the BAPTA internal is expected to reduce the [Ca2+]i during these events, so the 
fact that sheaths shortened in this condition (Fig. 3k) suggests that a BAPTA-induced 
reduction of magnitude of the brief [Ca2+]i transients dominates the effect on sheath length, 
or that the large Ca2+ entry occurring during bursts overwhelms the BAPTA buffer. 
Our data show that, like astrocytes16, developing oligodendrocytes in vivo exhibit 
spatially-restricted [Ca2+]i elevations. At early developmental stages these can occur 
simultaneously in many cell processes (possibly due to simultaneous neuronal input), but as 
myelination proceeds they become independent in different growing sheaths (Fig. 1, Supp. 
Fig. 1). Approximately half of these transients are evoked by action potentials, as they are 
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blocked by TTX and their rate is increased by electrical stimulation (Fig. 2). They may be 
generated by synaptic input from unmyelinated axons12, although this is downregulated as 
oligodendrocytes mature17. The remainder of the transients appear to be generated 
spontaneously, perhaps by TRPA1 channels16 in oligodendrocyte sheaths18. Conceivably, 
since [Ca2+]i transients promote sheath growth, these spontaneous and activity-driven 
transients may underlie the activity-independent and activity-dependent forms of myelination 
reported previously10. 
Lengthening of the myelin sheath is driven by the rate of [Ca2+]i transients occurring 
(Fig. 3) and, below a certain rate, sheaths shorten, so a minimum [Ca2+]i transient rate may 
be needed to maintain sheath length. However, long duration [Ca2+]i bursts imparting a high 
calcium load are also associated with shortening. These results suggest that modest [Ca2+]i 
elevations trigger sheath elongation, while very low or excessively large rises lead to sheath 
shortening. The [Ca2+]i transients presumably control proteins regulating cytoskeletal growth 
and myelin assembly. A likely effector producing sheath elongation is the PI3K/Akt/mTOR 
pathway, which is Ca2+-activated19 and promotes myelin growth when activated in 
oligodendrocytes20. Although our observations are in developing oligodendrocytes, it will be 
intriguing to determine whether the same is true in established sheaths in adult animals, 
given that myelin plasticity is increasingly invoked as a mechanism for learning4,5, and during 
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Figure 1. Calcium transient properties change during oligodendrocyte development. 
(a-c) Oligodendrocyte morphology at different developmental stages (3 cells from different 
CRISPR/Cas9-injected tg(sox10:mRFP) fish for each stage): (a) pre-OLs, before sheaths 
have been initiated; (b) early-OLs, when some sheaths have been initiated; (c) OLs, when 
all sheaths have been initiated. (d-f) Specimen [Ca2+]i traces for 3 developmental stages 
showing: (top) sequentially-recorded traces for the somata of 6 cells, and (bottom) 
simultaneously-recorded traces in different processes of a single cell of each class. A [Ca2+]i 
rise (red triangle) occurs simultaneously in 4 processes in d. (g-i) Rate, duration and 
amplitude of the transients at the 3 developmental stages (n=10 pre-OLs, 8 early-OLs and 8 
OLs from 5, 6 and 6 animals respectively). P values are from 2-tailed tests: one-way ANOVA 
followed by Holm-Bonferroni-corrected t-tests in g for ‘all processes’, and h and i for 
‘processes’; Kruskal-Wallis followed by Dunn’s test in g for ‘per process’ and ‘somata’, and in 
h and i for ‘somata’; two-way ANOVA followed by Holm-Sidak in h and i for ‘somata’ vs. 
‘processes’. Data are mean±SEM.  
Figure 2. Neuronal activity evokes half the calcium transients in developing 
oligodendrocytes. 
(a) Stimulating spinal cord rostral to the imaged area, and recording evoked activity caudally. 
In some experiments, TTX or Sham injections were into the hindbrain; 15 mins was allowed 
for diffusion to the imaged area. (b) Stimulation: 50 Hz pulses for 10 seconds, repeated 7 
times every 100 seconds. (c) Field potential recording (at 1 Hz) before and after TTX (9 
animals) or Sham solution (8 animals) injection showed abolition by TTX but not Sham. 
Calcium imaging was performed before and after the injection (red vertical lines). (d-e) 
[Ca2+]i traces (mean±SEM in grey) averaged over 7 periods without or with stimulation (red 
rectangles) in (d) 18 Non-sheath forming or (e) 45 Sheath forming processes. (f-g) 
Mean±SEM (points are individual processes) rate of [Ca2+]i transients without and with 
stimulation in (f) Non-sheath forming or (g) Sheath forming processes. (h-k) As for d-g but 
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for somata (9 each for j and k). Experiments in d-k were from 5 animals. (l-m) Rate of [Ca2+]i 
transients before and after Sham or TTX injections in (l) Non-sheath forming (27 and 32 
processes for Sham and TTX respectively) or (m) Sheath forming processes (59 and 61 
processes for Sham and TTX). (n-o) As for l-m but for somata (18 and 19 somata for Sham 
and TTX in n; 25 and 27 somata for Sham and TTX in o). Number of animals for l-o was as 
in c. Statistical tests (2-tailed) used: Wilcoxon signed rank test in f, g, j; paired t-test in k; 
repeated measures ANOVA followed by Holm-Sidak for I, m-o. Data are mean±SEM. 
Figure 3. Myelin sheath elongation correlates with calcium transient rate. 
(a) Schematic of calcium imaging protocol. (b) Specimen images (5 hours apart) of tg(mbp: 
mCherry-CAAX) (hotter colours indicate more fluorescence, left scale) in developing 
oligodendrocytes. Red, blue and white arrows indicate sheaths that became longer, shorter 
or did not change length, respectively, over 5 hours. Experiments were repeated six times 
with similar results. (c-e) Sheath behaviour over time in 3 cells to illustrate diversity of 
behaviour. Pie charts show percentage of sheaths growing (red; 75% in c, 42.9% d, 37.5% 
e), growing then shortening (purple; 25% c, 14.3% d), shortening (blue; 14.3% d, 62.5% e), 
and not changing length (black; 28.6% d). (f) Change of sheath length over 5 hours as a 
function of mean [Ca2+]i transient rate (see Online Methods) in 68 sheaths. (g) Increase of 
sheath length per hour and [Ca2+]i transient rate in 14 sheaths which were of constant length 
for at least 1 hour before lengthening started (at t=0). Data are mean±SEM. (h) Protocols for 
experiments in i (top) and j (bottom). Large lines: structural stack acquisition; small red lines: 
stimulation. (i-j) Sheath growth over 5 hours in (i) 78 sheaths in 5 sham-stimulated fish and 
71 sheaths in 5 stimulated fish, and (j) 99 sheaths in 6 sham-injected fish and 93 sheaths in 
6 TTX-injected fish (box and whisker plots show median, 25th and 75th centiles, and most 
extreme data values). (k) Sheath growth over 3 hours for oligodendrocytes briefly whole-cell 
clamped with internal solution containing 1 mM EGTA (Ctrl, 24 sheaths from 6 fish) or 30 
mM BAPTA (21 sheaths from 5 fish). (l) Percentage of sheaths with different growth 
behaviour (G, growth; 0, no change, G->S, growing then shortening, S, shortening) 
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exhibiting >1 Ca2+ transients in the 63 mins imaged over 5 hours (black, left axis) or showing 
[Ca2+]i bursts (red, right axis). Insets show specimen transients and bursts (scale bars 1 min 
and F/F=1). Different growth states are associated with significantly different numbers of 
transients (Chi-squared p=10-5, n=68 sheaths from 6 animals) and bursts (p=9x10-4). 
Because [Ca2+]i was only sampled for 10.5 mins per hour, and bursts are rare, it is possible 
that all (rather than 33% of) shortening sheaths experience [Ca2+]i bursts. Two-tailed 
statistical tests used: linear regression t-statistic in f; Mann-Whitney in i, j; unpaired t-test in 





The following transgenic zebrafish lines were used: tg(sox10:mRFP)vu234Tg (ref. 21, 
kindly provided by D. Lyons, Edinburgh) and two lines generated in house, tg(mbp:mCherry-
CAAX)u4011 and tg(sox10:GCaMP6s)u4016. The red-fluorescing tg(sox10:mRFP) and 
tg(mbp:mCherry) lines were used to visualise oligodendrocyte structure early and late in 
development, respectively, and the green-fluorescing tg(sox10:GCaMP6s) line was used to 
detect [Ca2+]i changes. To visualise the morphology of single cells, CRISPR/Cas9 was used 
to achieve mosaic expression of the mRFP fluorophore (see below). All experiments were 
performed in the non-pigmented nacre background (mitfaw2/w2). Embryos were collected by 
natural spawning, and raised at 28.5°C in fish water. Animal procedures were carried out in 
accordance with the guidelines of the UK Animals (Scientific Procedures) Act 1986 and 
European Directive 2010/63/EU. Animals were randomly assigned to different treatments. 
Plasmid construction  
Constructs were generated with Gateway cloning technology using the clones p5E-
mbp22, p5E-sox10 (generated by excising the sox10 promoter from23 p-4.9sox10:egfp and 
ligating into p5E-MCS), pME-GCaMP6s (generated in a BP reaction from pGP-CMV-
GCaMP6s [Addgene]) and components of the Tol2kit24: p3E-polyA, pME-mCherryCAAX, 
pDestTol2pA2 and pDestTol2CG2. Vectors were recombined using LR clonase II Plus 
(Invitrogen). Gateway BP clonase II was used to generate pME-GCaMP6s. 
Generation of transgenic zebrafish lines  
Fertilized eggs were injected with 1 nl of solution containing 25 ng/μl of plasmid DNA 
and 100 ng/μl of transposase mRNA. Injected embryos were grown to adulthood and F1 
offspring were screened by phenotype (expression of fluorescent protein in the appropriate 
cells) to identify F0 founders. 
CRISPR mosaics 
We used CRISPR/Cas9 genome editing to perform somatic inactivation (in most 
cells) of the mRFP transgene in a stable transgenic fish line tg(sox10:mRFP)vu234Tg in order 
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to allow visualisation of single developing oligodendrocytes. Guide RNA design was 
performed25 with CHOPCHOP (https://chopchop.rc.fas.harvard.edu/) using the mRFP 
sequence as input. One to 16 cell stage embryos were injected with 150 pg Cas9 and 30 pg 
mRFP gRNA (with target sequence GGCGAGGGCCGCCCCTACG), and embryos were 
selected for imaging based on their mosaic expression of the fluorescent marker.  
Live imaging  
At 3 days post fertilisation (dpf) larvae were mounted in 1% LMP agarose (Sigma, 
made up in fish water) in 0.5 mg/ml mivacurium chloride (LKT labs, a neuromuscular blocker 
used to prevent movement) and imaged at 28-29oC with a Zeiss LSM780 two-
photon/confocal microscope. A confocal stack was taken in an area between segments 8 
and 14 of the spinal cord, to record the morphology of developing oligodendrocytes 
(sox10:mRFP or mbp:mCherry-CAAX, excited at 561 nm). In calcium imaging experiments 
GCaMP6s was two-photon excited at 940 nm, with an intensity at the preparation of 11 mW 
and a pixel dwell time of 2.55 sec, using a W Plan-Apochromat  x20 objective with NA=1.0. 
Stacks of 5 planes, 2 m apart, were acquired every 3.5 s for 10.5 min (180 stacks). In Fig. 1 
calcium imaging was performed once for each field of view, in Fig. 2 twice for each field of 
view (control and stimulation, or control and TTX or sham injection) and in Figs. 3a-g and 3l 
six times (every hour for 5 hours, see Fig. 3a). The spatial resolution provided by 2-photon 
imaging did not allow us to define whether sheath [Ca2+]i transients occur between the 
lamellae of the developing sheath or in the cytoplasmic tongues extending along the sheath. 
Lengths of myelin sheaths were measured in a maximum intensity projection of the 
GCaMP6s images, i.e. averaged over the 10.5 mins of calcium imaging. This procedure was 
shown (in control experiments) to give the same measured length as when measuring the 
tg(sox10:RFP) or tg(mbp:mCherry) images. It is not possible to tell from our images the 
extent to which the sheaths have started compacting at the stage imaged (compaction is a 
gradual process, starting in the outer wraps, that occurs only as the sheath develops26). This 
does not affect our conclusions in any way, since the great majority of the sheaths we are 
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studying are destined to become compacted26,15 (and only a small fraction of sheaths are 
removed15). 
Image analysis  
Regions of interest (ROIs) were drawn for each non-sheath process (the terminal ~2-
5 m portion of a non-myelinating process) or sheath. The GECIquant 1.0 plugin27 for 
ImageJ was used to create time profiles of F/F, where F is the fluorescence of GCaMP6. In 
MATLAB, for each ROI we calculated a locally time-smoothed baseline (using 
uk.mathworks.com/matlabcentral/fileexchange/24916-baseline-fit with the piecewise cubic 
Hermite interpolating polynomial uk.mathworks.com/help/matlab/ref/pchip.html) with a 
smoothing time of 60 frames for cell processes and 120 frames for somata (which have 
longer [Ca2+]i transients). Then, we defined [Ca2+]i elevations of potential interest, using a 
detection threshold set to 2.25 x standard deviation of the first 100 points in the trace with 
F/F<0.75 (to exclude contributions of [Ca2+]i transients to the baseline) for the processes 
and set to 1 x standard deviation of the first 100 points in the trace with F/F<0.2 for the 
somata (somata data were subsequently smoothed by averaging each 2 adjacent points). 
These [Ca2+]i elevations were then further selected or rejected in the supra-threshold graph 
using a minimal area criterion (ʃ [F/F] dt > 0.275 frames for processes and > 0.24 frames for 
somata). Results of these analyses, which were carried out in MATLAB, were manually 
checked against the original GCaMP6s recordings to exclude false positives (resulting from 
increases in background activity, or activity in other cell processes). In Fig. 1g transient rate 
is shown for ‘Somata’ (averaged over cells), ‘Per process’ (calculated by obtaining the mean 
rate per process for each cell and then calculating the mean±SEM by averaging over all 
cells), and for ‘All processes’ (calculated by averaging over all cells the product of [mean rate 
per process for each cell].[number of processes on the cell]). 
Duration of transients or bursts (Fig. 1h, Supp. Fig. 2b) was taken as the time for 
which they were above the detection threshold. Amplitude (Fig. 1i, Supp. Fig. 2a) was taken 
as the magnitude of F/F at the peak of the response relative to the time-smoothed baseline. 
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Transient area (Supp. Fig. 2c) was taken as the sum of: (i) the area of the transient above 
the threshold, and (ii) its ‘base’, taken as the duration of the transient multiplied by the 
threshold value (which is the area of the transient below the threshold). Rarely observed 
[Ca2+]i bursts, defined as periods of raised [Ca2+]i, with frequently alternating sub- and 
suprathreshold values of F/F, with the suprathreshold events constituting at least 55% of 
the frames, and with an overall duration greater than 40 sec, were excluded from the 
analysis of transients for Fig. 3f, and analysed separately for Fig. 3l. Burst area was 
calculated as the sum of the areas of each supra-threshold component of the burst plus its 
‘base’. Mean burst amplitude was calculated as the burst area divided by its duration. The 
average rate (Fig. 3f), amplitude, duration and area (Supp. Fig. 2a-c) of calcium transients 
were calculated using the flanking calcium recordings to obtain an average for each hour 
and then taking the sum of those and dividing it by the total duration of the experiment. 
Electrical stimulation and pharmacology 
 A stimulation electrode (glass capillary filled with 1M NaCl) was inserted in the rostral 
spinal cord. For recording field potentials, a similar electrode (tip resistance 15–35 M inside 
the spinal cord) was placed in the caudal spinal cord. Stimuli (single pulses applied at 1 Hz, 
or 50 Hz stimulus trains of 10 s duration) were generated with a GRASS S88 stimulator 
triggered with Clampex software (Axon Instruments, Molecular Devices). For these 
experiments the fish was surrounded by fish extracellular solution (134 mM NaCl, 10 mM 
HEPES, 10 mM glucose, 2.9 mM KCl, 2.1 CaCl2, and 1.2 mM MgCl2) rather than fish water, 
to allow better current flow from the stimulation electrode to the ground electrode. Field 
potentials (for TTX experiments measured in voltage-clamp mode as currents) were 
recorded using an Axon Instruments MultiClamp 700B amplifier. Data were digitized at 10 
kHz using an Axon Instruments Digidata 1440 (Molecular Devices). Stimulation strength was 
set to 15–100 V (depending on the electrode resistance) to reliably evoke field potentials. 
When imaging calcium with and without stimulation (Fig. 2b, d-k), the periods of stimulation 
and no stimulation (control) were alternated, and [Ca2+]i transient rate was measured in a 
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40s time window which included the 10s stimulation and the 30s post-stimulation periods 
(equivalent time windows were analysed in the control experiments where no stimulation 
was applied). To block action potentials in the spinal cord, 2 nl of fish extracellular solution 
containing 2 M TTX was pressure injected into the brain using a Picospritzer III (Parker). 
Injections were calibrated to deliver 0.5 µl per pressure pulse (4 pulses were used for 2 µl). 
For control injections (sham), the same volume of extracellular solution lacking TTX was 
injected (no blinding of experimenters to the identity of the injected solution was used for 
these experiments). Movement of TTX from the injection site to the spinal cord (to inhibit 
action potentials) took <1 min, and we waited 15 mins to ensure that it reached the imaging 
site (Fig. 2c). Experiments in Fig. 3i had the stimulation and recording electrodes inserted 
but not the injection pipette; experiments in Fig. 3j had injection pipette inserted but not the 
stimulation and recording electrodes.  
Whole-cell patch-clamp loading of calcium buffer into oligodendrocytes in vivo 
After immobilization using 0.50–0.55 mg/ml mivacurium chloride dissolved in fish 
external solution, fish were pinned through the notochord to a sylgard-coated recording 
chamber using fine tungsten needles. The skin was removed using a tungsten tool and fine 
tweezers, and the muscles aspirated using a suction electrode. Oligodendrocytes were 
identified by mCherry expression and patch-clamped using 15-18 M patch pipettes. 
Directly after establishing the whole-cell configuration (with cells voltage-clamped at -55mV), 
4-5 brief “zaps” (25 µs, 1 volt pulse, applied from the Multiclamp 700B amplifier) were 
applied to load the cell with the internal solution (monitored by the spread of the Alexa Fluor 
647 dye included in the internal solution). Directly after zapping, the patch pipette was 
retracted carefully to allow the membrane to reseal (monitored in voltage-clamp mode). The 
tissue was allowed to relax for approximately 15 minutes before imaging. Image stacks 
(image size 70.7 µm x 41.4 m, pixel size 0.14 m, z step size 1 µm) of the patch-clamp 
loaded oligodendrocytes were taken every hour for a period of 3 hours. 
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The control (low calcium buffer) internal solution contained (in mM) 125 potassium 
gluconate, 2 NaCl, 0.2 CaCl2, 10 HEPES, 1 EGTA, 2 MgCl2, 2 Mg-ATP, 0.5 Na2-GTP, 10 
Na2-phosphocreatine and 0.1 Alexa Fluor 647, with pH set to 7.1 using KOH. The high 
calcium buffering power internal solution contained BAPTA (tetrapotassium salt) and was 
similar, but with the CaCl2 and EGTA replaced with (in mM) 7 CaCl2 and 30 BAPTA, and with 
osmolarity differences compensated by lowering the potassium gluconate concentration. The 
solution contained (in mM) 63 K-gluconate, 2 NaCl, 7 CaCl2, 10 HEPES, 30 K4-BAPTA, 2 
MgCl2, 2 Mg-ATP, 0.5 Na2-GTP, 10 Na2-phosphocreatine and 0.1 Alexa Fluor 647, with pH 
set to 7.1 using KOH. The free [Ca2+]i was ~63 nM in both internal solutions, calculated using 
MaxChelator (http://maxchelator.stanford.edu/webmaxc/webmaxcS.htm) with the 
temperature set to 28°C and ionic strength set to 140 mM. 
The experimenter was blinded as to whether the pipette contained the low or high 
calcium buffer solution. 
Statistics 
 Data are shown as mean±SEM, with individual data points superimposed. N 
numbers used for statistics were of cell processes, sheaths or somata, as appropriate. 
Normality of data was verified using the D’Agostino & Pearson omnibus test and equality of 
variance tested using the F-statistic. Normally distributed data were analysed using ANOVA 
and post-hoc t-tests, or paired t-tests, as appropriate. For t-tests, data were compared to 
interleaved controls using a homoscedastic, two-sided Student’s t-test (equal variance), 
except where the variances of the data were unequal, when a heteroscedastic, two-sided 
Student’s t-test was used. Data were corrected for multiple comparisons within figure panels 
using a procedure equivalent to the Holm-Bonferroni method (for N comparisons, the most 
significant p value is multiplied by N, the 2nd most significant by N-1, the 3rd most significant 
by N-2, etc.; corrected p values are significant if they are less than 0.05). Non-normally 
distributed data were analysed with (two-tailed) Kruskal-Wallis tests followed by Dunn’s 
multiple comparison tests, or Wilcoxon tests, as appropriate (in GraphPad Prism). 
Differences between processes and somata in Fig. 1h-i were analysed with a two-way 
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ANOVA followed by Holm-Sidak’s multiple comparison test. Data in Fig. 2l-o were analysed 
with a two-way repeated measures ANOVA followed by Holm-Sidak’s multiple comparison 
test. Comparisons of the slopes of linear regressions with a slope of zero were performed 
using the t-statistic for the regression. Comparison of the numbers of [Ca2+]i transients or 
bursts in different process categories was done with Chi-squared tests. Further details of 
statistical tests are available in Supplementary Table 1. 
An estimate of the sample size needed for a typical experiment is as follows. For a 
control response of 100%, a typical response standard deviation of 40%, a response at a 
different developmental stage of 30% (70% less), a power of 80% and p<0.05, 7 cell 
processes are needed (http://www.biomath.info/power/ttest.htm) in each of the two groups. 
The exact numbers depend on the effect size and standard error of the data. 
Data availability 
 The data that support the findings of this study are available from the corresponding 
author upon reasonable request. The MATLAB code used can be obtained from 








 TTX citrate was obtained from Abcam and mivacurium chloride from LKT labs. Other 
chemicals were from Sigma. 
Data and Code Availability 
Available from the corresponding author upon request. 
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Supplementary Figure Legends 
Supplementary Figure 1. Synchronicity of [Ca2+]i transients in different cell regions. 
(a-c) Charts: Fraction of time (Probability) that the number of processes on the abscissa (N) 
had a simultaneous [Ca2+]i elevation, in (a) pre-OLs, (b) early-OLs and (c) OLs from 5, 6 and 
6 animals respectively (mean values, shown as horizontal lines with SEM bars, that are 
below all visible individual data points reflect some data points being zero and hence not 
plotted on the logarithmic scale charts). Inset tables: Observed distribution of probability as 
in main graphs, and predicted distribution calculated as follows. If the probability of a single 
observed process having a high [Ca2+]i is denoted p1 (this was derived experimentally for 
each process and averaged over all the processes of each individual cell), and there are N 






. These are the predicted values in the inset tables, when averaged 
over all cells. The observed values for the fraction of time that 2 or more processes 
simultaneously showed a high [Ca2+]i were greater than predicted for pre-OLs and early-OLs, 
implying cooperativity of transient generation between processes or propagation of 
transients from one process into another, but not for OLs (see 2-sided Chi-squared p values 
for inset tables). (d-f) Probabilities of N (abscissa) processes having high [Ca2+]i 
simultaneously and having the soma [Ca2+]i low (black bars) or high (i.e. during a soma 
[Ca2+]i transient, grey bars), for each of the 3 classes of cell. (g-i) Cumulative probability 
distributions for the data in d-f, with p values from Kolmogorov-Smirnov tests comparing the 
distributions for each cell class. When the soma [Ca2+]i was high in early-OLs, there was a 
larger probability for 1 or more processes to have an elevated [Ca2+]i, than was the case 
when the soma [Ca2+]i was low. Soma transients occurred with a probability of 0.10, 0.08 
and 0.02 for pre-OLs, early-OLs and OLs, respectively, and so the majority of [Ca2+]i 
transients in processes occurred when soma [Ca2+]i was low. In OLs in particular, processes 
only showed [Ca2+]i elevations when the soma [Ca2+]i was low, and the data in panel c imply 
that [Ca2+]i transients in different myelin sheaths are independent of each other. (j-l) 
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Probability of the soma [Ca2+]i being high when the number of processes on the abscissa 
simultaneously exhibited high [Ca2+]i for each of the 3 classes of cell. For pre-OLs the 
probability of the soma [Ca2+]i being high is increased when more processes have a 
simultaneously high [Ca2+]i (p=0.0024, ANOVA) indicating that gene expression might be 
controlled by somatic [Ca2+]i elevations triggered by simultaneous activity-evoked transients 
in several processes on the same developing oligodendrocyte. For early-OLs the increase of 
probability with number of processes simultaneously exhibiting high [Ca2+]i did not reach 
significance (p=0.86, Kruskal-Wallis test). For OLs, the soma [Ca2+]i was never high when 
process [Ca2+]i was high. All data are mean±SEM.  
Supplementary Figure 2. Dependence of sheath elongation on [Ca2+]i properties. 
(a-c) Change of sheath length (in 68 sheaths from 6 animals) correlates significantly with 
sheath [Ca2+]i transient (a) duration, (b) amplitude and (c) area (ʃ[F/F] dt). (d) Change of 
sheath length does not correlate significantly with soma [Ca2+]i transient rate (in 54 sheath-
soma pairs from 6 animals). (e) Increase of sheath length and [Ca2+]i transient rate in 14 
lengthening sheaths which were of constant length for at least 1 hour before lengthening 
started, with data aligned at t=0 at the start of growth. [Ca2+]i transients precede sheath 
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 Supplementary Figure 1 
Synchronicity of [Ca2+]i transients in different cell regions. 
(a-c) Charts: Fraction of time (Probability) that the number of processes on the abscissa (N) had a simultaneous [Ca2+]i elevation, in (a) 
pre-OLs, (b) early-OLs and (c) OLs from 5, 6 and 6 animals respectively (mean values, shown as horizontal lines with SEM bars, that 
are below all visible individual data points reflect some data points being zero and hence not plotted on the logarithmic scale charts). 
Inset tables: Observed distribution of probability as in main graphs, and predicted distribution calculated as follows. If the probability of 
a single observed process having a high [Ca2+]i is denoted p1 (this was derived experimentally for each process and averaged over all 
the processes of each individual cell), and there are N processes, the probability of k processes exhibiting calcium transients 
simultaneously is: . These are the predicted values in the inset tables, when averaged over all cells. The 
observed values for the fraction of time that 2 or more processes simultaneously showed a high [Ca2+]i were greater than predicted for 
pre-OLs and early-OLs, implying cooperativity of transient generation between processes or propagation of transients from one process 
into another, but not for OLs (see 2-sided Chi-squared p values for inset tables). (d-f) Probabilities of N (abscissa) processes having 
high [Ca2+]i simultaneously and having the soma [Ca2+]i low (black bars) or high (i.e. during a soma [Ca2+]i transient, grey bars), for each 
of the 3 classes of cell. (g-i) Cumulative probability distributions for the data in d-f, with p values from Kolmogorov-Smirnov tests 
comparing the distributions for each cell class. When the soma [Ca2+]i was high in early-OLs, there was a larger probability for 1 or 
more processes to have an elevated [Ca2+]i, than was the case when the soma [Ca2+]i was low. Soma transients occurred with a 
probability of 0.10, 0.08 and 0.02 for pre-OLs, early-OLs and OLs, respectively, and so the majority of [Ca2+]i transients in processes 
occurred when soma [Ca2+]i was low. In OLs in particular, processes only showed [Ca2+]i elevations when the soma [Ca2+]i was low, and 
the data in panel c imply that [Ca2+]i transients in different myelin sheaths are independent of each other. (j-l) Probability of the soma 
[Ca2+]i being high when the number of processes on the abscissa simultaneously exhibited high [Ca2+]i for each of the 3 classes of cell. 
For pre-OLs the probability of the soma [Ca2+]i being high is increased when more processes have a simultaneously high [Ca2+]i 
(p=0.0024, ANOVA) indicating that gene expression might be controlled by somatic [Ca2+]i elevations triggered by simultaneous activity-
evoked transients in several processes on the same developing oligodendrocyte. For early-OLs the increase of probability with number 
of processes simultaneously exhibiting high [Ca2+]i did not reach significance (p=0.86, Kruskal-Wallis test). For OLs, the soma [Ca2+]i 
was never high when process [Ca2+]i was high. All data are mean±SEM. 
 Supplementary Figure 2 
Dependence of sheath elongation on [Ca2+]i properties. 
(a-c) Change of sheath length (in 68 sheaths from 6 animals) correlates significantly with sheath [Ca2+]i transient (a) duration, (b) 
amplitude and (c) area (ʃ[F/F] dt). (d) Change of sheath length does not correlate significantly with soma [Ca2+]i transient rate (in 54 
sheath-soma pairs from 6 animals). (e) Increase of sheath length and [Ca2+]i transient rate in 14 lengthening sheaths which were of 
constant length for at least 1 hour before lengthening started, with data aligned at t=0 at the start of growth. [Ca2+]i transients precede 
sheath growth by ~1 hour. Data are mean±SEM. 
 
